Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA1795564
Max Phase: Preclinical
Molecular Formula: C16H12Cl3FN5O6PS
Molecular Weight: 558.70
Molecule Type: Small molecule
Associated Items:
ID: ALA1795564
Max Phase: Preclinical
Molecular Formula: C16H12Cl3FN5O6PS
Molecular Weight: 558.70
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CO/N=C(\C(=O)NCP(=O)(O)Oc1ccc(C#N)c(F)c1)c1cnc(NC(=O)C(Cl)(Cl)Cl)s1
Standard InChI: InChI=1S/C16H12Cl3FN5O6PS/c1-30-25-12(11-6-22-15(33-11)24-14(27)16(17,18)19)13(26)23-7-32(28,29)31-9-3-2-8(5-21)10(20)4-9/h2-4,6H,7H2,1H3,(H,23,26)(H,28,29)(H,22,24,27)/b25-12-
Standard InChI Key: JWUGNDFPWIALBB-ROTLSHHCSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 558.70 | Molecular Weight (Monoisotopic): 556.9296 | AlogP: 3.15 | #Rotatable Bonds: 8 |
Polar Surface Area: 163.00 | Molecular Species: ACID | HBA: 9 | HBD: 3 |
#RO5 Violations: 1 | HBA (Lipinski): 11 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 1.56 | CX Basic pKa: | CX LogP: 2.87 | CX LogD: 0.25 |
Aromatic Rings: 2 | Heavy Atoms: 33 | QED Weighted: 0.19 | Np Likeness Score: -1.30 |
1. Tan Q, Ogawa AM, Raghoobar SL, Wisniewski D, Colwell L, Park YW, Young K, Hermes JD, Dininno FP, Hammond ML.. (2011) Thiophenyl oxime-derived phosphonates as nano-molar class C beta-lactamase inhibitors reducing MIC of imipenem against Pseudomonas aeruginosa and Acinetobacter baumannii., 21 (14): [PMID:21664132] [10.1016/j.bmcl.2011.04.122] |
2. Tan Q, Ogawa AM, Raghoobar SL, Wisniewski D, Colwell L, Park YW, Young K, Hermes JD, Dininno FP, Hammond ML.. (2011) Thiophenyl oxime-derived phosphonates as nano-molar class C beta-lactamase inhibitors reducing MIC of imipenem against Pseudomonas aeruginosa and Acinetobacter baumannii., 21 (14): [PMID:21664132] [10.1016/j.bmcl.2011.04.122] |
Source(1):